Advanced Pharmacology Disorders
Advanced Pharmacology Disorders Name Academic Institution Advanced Pharmacology Disorders The health needs identified in the patient include the diagnosis of the disease and treatment. It is necessary to identify the disease the patient is suffering from as a result of diaphoresis, nausea, vomiting, and dyspnea (Reed, Rossi & Cannon, 2017). It is important to carry out intensive diagnosis to ascertain if the conditions she had in the past have reoccurred. Additionally, the diagnosis should establish why the patient has experienced angina in the recent past. Another health need is to assess the ST-segment and identify the relationship with other health complications such as the severity of myocardial infarction (Reed, Rossi & Cannon, 2017). The health needs also should comprise of health education to explain to the patient what is happening in the body. The health education will help the patient to make the right decisions when she is alone at home. It will also be essential in preventing adverse conditions that can be sophisticated or lead to preventable death. The patient is experiencing a heart problem which is characterized by sudden-onset diaphoresis, nausea, vomiting, and dyspnea. The treatment regimen will involve prescription of drugs such as Angiotensin-converting enzyme which is responsible for regulating blood pressure (Shi, Tao, Wei & Zhao, 2016). Additionally, the patient should take angiotensin II receptor blockers which are responsible for enlarging the blood vessels to reduce the blood pressure. The regulation is essential to prevent rapture of the vessels due to constriction. The patient is experiencing diaphoresis due to sudden blockage of the coronary arteries (Palacios, Khondoker, Mann, Tylee & Hotopf, 2017). Taking the medication that enlarges the blood vessels and regulates the blood pressure thus reducing the pain and the sudden effect. It is also important for the patient to take beta-blockers which reduce the blood pressure by causing the heart to beat slowly. The treatment regimen should also involve resting which will help the patient regulate the diaphoresis. It is also important to take X-ray images to show the condition of the heart and any blockage of coronary arteries that could be affecting the heart. The medication to be prescribed to the patient will be considerate of their age and the condition they are currently experiencing. The considerations will avoid cases of overdose or overreaction to the disease (Meibom et al., 2017). The age of the patient means that some of the organs are weak and thus they should not be subjected to strong medication. The education strategy is to inform the patient of what happened to their body. It is important to explain to the patient in plain language the risks they face. The strategy will involve identifying the areas that require improvement such as eating healthy and taking regular exercises (Cai et al., 2017). For example, the patient should avoid cholesterol which increases the risk of blockage of blood vessels. The patient should also take their medication regularly. The patient should also involve the family members to ensure they are aware of the risks she is prone to. Conclusion Heart problem is one of the major causes of death in the world. Patients with heart diseases should seek immediate care to prevent adverse complications or death. It is also important to devise treatment regimen which will be appropriate for the patient depending on their age. One of the major causes of heart problems is blockage of the blood vessels. The patient should take medication that regulates blood pressure and dilates the blood vessels. References Cai, S., Coates, A. M., Buckley, J. D., Berry, N. M., Burres, L., Beltrame, J., ... & Schrader, G. (2017). There is no association between the omega-3 index and depressive symptoms in patients with heart disease who are low fish consumers. Heart, Lung and Circulation, 26(3), 276-284. Meibom, D., Albrecht‐Küpper, B., Diedrichs, N., Hübsch, W., Kast, R., Krämer, T., ... & Süssmeier, F. (2017). Neladenoson bialanate hydrochloride: a prodrug of a partial adenosine A1 receptor agonist for the chronic treatment of heart diseases. ChemMedChem, 12(10), 728-737. Palacios, J., Khondoker, M., Mann, A., Tylee, A., & Hotopf, M. (2017). Trajectories of depression and anxiety symptoms in coronary heart disease strongly predict health care costs. European Psychiatry, 41, S312-S313. DOI: Reed, G. W., Rossi, J. E., & Cannon, C. P. (2017). Acute myocardial infarction. The Lancet, 389(10065), 197-210. Shi, A., Tao, Z., Wei, P., & Zhao, J. (2016). Epidemiological aspects of heart diseases. Experimental and Therapeutic Medicine, 12(3), 1645-1650.